TY - JOUR
T1 - Identification of DNA response elements regulating expression of CCAAT/enhancer-binding protein (C/EBP) β and δ and MAP kinase-interacting kinases during early adipogenesis
AU - Merrett, James E.
AU - Bo, Tao
AU - Psaltis, Peter J.
AU - Proud, Christopher G.
N1 - Funding Information:
This work was supported by funding from the South Australian Health and Medical Research Institute. JEM acknowledges the support received through the provision of an Australian Government Research Training Program Scholarship. PJP is supported by an L2 Future Leader Fellowship from the National Heart Foundation of Australia [FLF102056] and L2 Career Development Fellowship from the National Health and Medical Research Council [CDF1161506]. The 3T3-L1 fibroblasts used in this study were generously provided by Yeesim Khew-Goodhall from the Centre for Cancer Biology (SA Pathology). We thank Dr Jianling Xie (SAHMRI) for his excellent assistance with aspects of this study and Professor Murray Whitelaw (University of Adelaide) for valuable advice.
PY - 2020
Y1 - 2020
N2 - Given the high and increasing prevalence of obesity and associated disorders, such as type-2 diabetes, it is important to understand the mechanisms that regulate lipid storage and the differentiation of fat cells, a process termed adipogenesis. Using the well-established mouse 3T3-L1 in vitro model of adipogenesis, we refine how the induction of two key adipogenic transcription factors, CCAAT/enhancer-binding proteins (C/EBPs) β and δ are regulated during early adipogenesis. We identify, in the gene promoters of Cebpb and Cebpd, the DNA response elements responsible for binding transcription factors that are activated by cAMP or glucocorticoids. We also show that mitogen-activated protein kinase (MAPK)-interacting kinase 2 (MNK2; Mknk2), which plays a distinct role in diet-induced obesity, is induced during early adipogenesis and identify the functional DNA response elements responsible for regulating its expression. Mknk2 expression is maintained in differentiated 3T3-L1 adipocytes and is expressed at high levels across a range of mouse adipose tissue depots. Together, these new insights help to clarify the transcriptional programme of early adipogenesis and identify Mknk2 as one of potentially many genes up-regulated during adipogenesis.
AB - Given the high and increasing prevalence of obesity and associated disorders, such as type-2 diabetes, it is important to understand the mechanisms that regulate lipid storage and the differentiation of fat cells, a process termed adipogenesis. Using the well-established mouse 3T3-L1 in vitro model of adipogenesis, we refine how the induction of two key adipogenic transcription factors, CCAAT/enhancer-binding proteins (C/EBPs) β and δ are regulated during early adipogenesis. We identify, in the gene promoters of Cebpb and Cebpd, the DNA response elements responsible for binding transcription factors that are activated by cAMP or glucocorticoids. We also show that mitogen-activated protein kinase (MAPK)-interacting kinase 2 (MNK2; Mknk2), which plays a distinct role in diet-induced obesity, is induced during early adipogenesis and identify the functional DNA response elements responsible for regulating its expression. Mknk2 expression is maintained in differentiated 3T3-L1 adipocytes and is expressed at high levels across a range of mouse adipose tissue depots. Together, these new insights help to clarify the transcriptional programme of early adipogenesis and identify Mknk2 as one of potentially many genes up-regulated during adipogenesis.
KW - Adipogenesis
KW - CCAAT/enhancer‐binding protein (C/EBP)
KW - MAPK-interacting kinase (MNK)
KW - adipocyte
KW - cAMP response element‐binding protein (CREB)
KW - cyclic AMP (cAMP)
KW - glucocorticoid
KW - glucocorticoid receptor
UR - http://www.scopus.com/inward/record.url?scp=85089425757&partnerID=8YFLogxK
U2 - 10.1080/21623945.2020.1796361
DO - 10.1080/21623945.2020.1796361
M3 - Article
C2 - 32787498
AN - SCOPUS:85089425757
VL - 9
SP - 427
EP - 442
JO - Adipocyte
JF - Adipocyte
SN - 2162-3945
IS - 1
ER -